Global Retirement Partners LLC acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 3,231 shares of the semiconductor company’s stock, valued at approximately $1,441,000.
Several other hedge funds have also added to or reduced their stakes in SNPS. Sankala Group LLC purchased a new position in Synopsys in the fourth quarter valued at about $25,000. Elevation Wealth Partners LLC increased its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys in the 4th quarter worth approximately $28,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys in the 1st quarter worth approximately $30,000. Finally, Atlas Capital Advisors Inc. purchased a new position in Synopsys in the fourth quarter valued at approximately $32,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $413.22 on Tuesday. The company has a 50 day moving average of $424.42 and a 200 day moving average of $442.30. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $626.24. The stock has a market cap of $79.12 billion, a P/E ratio of 95.65, a P/E/G ratio of 2.48 and a beta of 1.23.
Insider Activity
In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on SNPS. Citigroup boosted their target price on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Benchmark began coverage on shares of Synopsys in a report on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price objective for the company. Rosenblatt Securities increased their target price on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research report on Tuesday, May 26th. Finally, Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and a consensus price target of $565.06.
Check Out Our Latest Stock Analysis on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
